| Mrs Barbara Ann Duncan-cody, MD | |
|
1174 Poplar Ave, Memphis, TN 38105-4805 | |
| (901) 278-1412 | |
| (901) 278-6972 |
| Full Name | Mrs Barbara Ann Duncan-cody |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 44 Years |
| Location | 1174 Poplar Ave, Memphis, Tennessee |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093866733 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207VX0000X | Obstetrics & Gynecology - Obstetrics | MD15413 (Tennessee) | Secondary |
| 207VG0400X | Obstetrics & Gynecology - Gynecology | MD15413 (Tennessee) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Methodist Healthcare Memphis Hospitals | Memphis, TN | Hospital |
| Entity Name | Memphis Health Center, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144236902 PECOS PAC ID: 7315859972 Enrollment ID: O20031103000245 |
News Archive
Vemma's second annual fundraising campaign for Children's Miracle Network kicks off this summer, June 1 - August 31, 2010. Funds raised will contribute to medical care, research and education throughout a network of 170 children's hospitals and foundations. Vemma NEXT, the company's liquid children's supplement, will play a key role in the fundraising effort.
Acorda Therapeutics, Inc. today announced top line results from a post-marketing commitment study evaluating a 5mg dose of dalfampridine-ER to improve walking in people with multiple sclerosis. The study failed to confirm efficacy of the 5mg dose.
Leading physician policy experts are calling for changes in medical education policy at multiple levels to ensure that doctors are prepared to treat the country's aging adult population.
Childrens Hospital Los Angeles has been awarded $7 million of a $56.8 million grant from the National Institutes of Health. The remainder of the award will be distributed to other members of the Los Angeles Basin Clinical and Translational Science Institute (CTSI). This award, to be distributed over five years, will fund biomedical research with the objective of reducing the time it takes a laboratory discovery to become a clinical reality.
Efforts to treat myotonic dystrophy type 1, the most common form of muscular dystrophy, are in their infancy. In a new study, researchers report they have added new capabilities to an experimental drug agent that previously defeated only one of DM1's many modes of action. Their retooled compounds interrupt the disease's pathology in three ways.
› Verified 9 days ago
| Entity Name | Barbara A. Duncan-cody, Md Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457557365 PECOS PAC ID: 5092047811 Enrollment ID: O20191029000973 |
News Archive
Vemma's second annual fundraising campaign for Children's Miracle Network kicks off this summer, June 1 - August 31, 2010. Funds raised will contribute to medical care, research and education throughout a network of 170 children's hospitals and foundations. Vemma NEXT, the company's liquid children's supplement, will play a key role in the fundraising effort.
Acorda Therapeutics, Inc. today announced top line results from a post-marketing commitment study evaluating a 5mg dose of dalfampridine-ER to improve walking in people with multiple sclerosis. The study failed to confirm efficacy of the 5mg dose.
Leading physician policy experts are calling for changes in medical education policy at multiple levels to ensure that doctors are prepared to treat the country's aging adult population.
Childrens Hospital Los Angeles has been awarded $7 million of a $56.8 million grant from the National Institutes of Health. The remainder of the award will be distributed to other members of the Los Angeles Basin Clinical and Translational Science Institute (CTSI). This award, to be distributed over five years, will fund biomedical research with the objective of reducing the time it takes a laboratory discovery to become a clinical reality.
Efforts to treat myotonic dystrophy type 1, the most common form of muscular dystrophy, are in their infancy. In a new study, researchers report they have added new capabilities to an experimental drug agent that previously defeated only one of DM1's many modes of action. Their retooled compounds interrupt the disease's pathology in three ways.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Barbara Ann Duncan-cody, MD 1174 Poplar Ave, Memphis, TN 38105-4805 Ph: (901) 278-1412 | Mrs Barbara Ann Duncan-cody, MD 1174 Poplar Ave, Memphis, TN 38105-4805 Ph: (901) 278-1412 |
News Archive
Vemma's second annual fundraising campaign for Children's Miracle Network kicks off this summer, June 1 - August 31, 2010. Funds raised will contribute to medical care, research and education throughout a network of 170 children's hospitals and foundations. Vemma NEXT, the company's liquid children's supplement, will play a key role in the fundraising effort.
Acorda Therapeutics, Inc. today announced top line results from a post-marketing commitment study evaluating a 5mg dose of dalfampridine-ER to improve walking in people with multiple sclerosis. The study failed to confirm efficacy of the 5mg dose.
Leading physician policy experts are calling for changes in medical education policy at multiple levels to ensure that doctors are prepared to treat the country's aging adult population.
Childrens Hospital Los Angeles has been awarded $7 million of a $56.8 million grant from the National Institutes of Health. The remainder of the award will be distributed to other members of the Los Angeles Basin Clinical and Translational Science Institute (CTSI). This award, to be distributed over five years, will fund biomedical research with the objective of reducing the time it takes a laboratory discovery to become a clinical reality.
Efforts to treat myotonic dystrophy type 1, the most common form of muscular dystrophy, are in their infancy. In a new study, researchers report they have added new capabilities to an experimental drug agent that previously defeated only one of DM1's many modes of action. Their retooled compounds interrupt the disease's pathology in three ways.
› Verified 9 days ago
Kristin M. Miller, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 6750 Poplar Ave, Suite 210, Memphis, TN 38138 Phone: 901-756-6522 Fax: 901-435-0928 | |
Dr. Jason Glenn Williams, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 6215 Humphreys Blvd, Ste 401, Memphis, TN 38120 Phone: 901-767-8442 Fax: 901-684-6260 | |
Dr. Owen P. Phillips, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 6215 Humphreys Blvd Ste 201, Memphis, TN 38120 Phone: 901-866-8085 Fax: 901-515-3429 | |
Claudia Leonard Moise, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 6215 Humphreys Blvd, Suite 401, Memphis, TN 38120 Phone: 901-767-8448 Fax: 901-684-6260 | |
Dr. Kingsley Ogonna Oraedu, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 6025 Walnut Grove Rd, Ste 316, Memphis, TN 38120 Phone: 901-274-9717 Fax: 901-684-2008 | |
Mitchell Scott Mcalister, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2400 Poplar Ave, Suite 501, Memphis, TN 38112 Phone: 901-271-0896 Fax: 901-271-0897 | |
Dr. Dwight Melvyn Moore, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1264 Wesley Dr, Ste 402, Memphis, TN 38116 Phone: 901-396-5577 Fax: 901-396-5585 |